CollPlant Biotechnologies (CLGN) Cash from Discontinued Operations (2020 - 2021)
CollPlant Biotechnologies (CLGN) posted Cash from Discontinued Operations of 2817000.0 for Q3 2021, up 13.59% on a QoQ basis from 3260000.0 in Q2 2021, and down 139.14% year-over-year from 7197000.0 in Q3 2020.
CollPlant Biotechnologies (CLGN) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends
CollPlant Biotechnologies' Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 2817000.0 for Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -2.82 Mn |
| Sep 30, 2021 | -2.82 Mn |
| Jun 30, 2021 | -3.26 Mn |
| Jun 30, 2021 | -3.26 Mn |
| Mar 31, 2021 | 11.00 Mn |
| Mar 31, 2021 | 11.00 Mn |
| Sep 30, 2020 | 7.20 Mn |
| Sep 30, 2020 | 7.20 Mn |
| Jun 30, 2020 | -1.76 Mn |
| Jun 30, 2020 | -1.76 Mn |
| Mar 31, 2020 | -2.59 Mn |
| Mar 31, 2020 | -2.59 Mn |